Detalhe da pesquisa
1.
Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 26(1): 197-203, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31518645
2.
Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome.
Bone Marrow Transplant
; 54(6): 839-848, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30258129